C-Arms International Inc is categorized under Medical Apparatus and Supplies in San Diego, CA and active since 1998.
C-Arms International Inc was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 446199 by the NAICS.
If you are seeking more information, feel free to contact Danny R Asbille at the company’s single location by writing to 10225 Barnes Canyon Road, San Diego, California CA 92121 or by phoning (858) 404-0100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | C-Arms International Inc |
Contact Person: | Danny R Asbille |
Address: | 10225 Barnes Canyon Road, San Diego, California 92121 |
Phone Number: | (858) 404-0100 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Apparatus and Supplies |
SIC Code: | 5999 |
NAICS Code: | 446199 |
Share This Business: |
C-Arms International Inc was started in 1998 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 446199. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Danny R Asbille for inquiries that concern C-Arms International Inc by calling the company number (858) 404-0100, as your correspondence is most welcome. Additionally, the physical location of the single location of C-Arms International Inc can be found at the coordinates 32.899938,-117.195887 as well as the street address 10225 Barnes Canyon Road in San Diego, California 92121.
For its online presence, you may visit C-Arms International Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.